In the shift toward a biological definition of Alzheimer’s disease (AD) [13], several AD-specific neuropathology biomarkers, such as amyloid and tau, have been proposed as core diagnostic criteria and potential targets for early detection in presymptomatic individuals. Here, MAPT is linked to Alzheimer disease.